{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:48:06Z","timestamp":1780764486390,"version":"3.54.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional De Promocion Cientifica Y Tecnologica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.peptides.2021.170570","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T11:33:39Z","timestamp":1620992019000},"page":"170570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses"],"prefix":"10.1016","volume":"142","author":[{"given":"Axel","family":"Hollmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Espeche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-2646","authenticated-orcid":false,"given":"Paulo C.","family":"Maff\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2021.170570_bib0005","first-page":"497","article-title":"The role of wildlife in emerging and re-emerging zoonoses","volume":"23","author":"Bengis","year":"2004","journal-title":"OIE Rev. Sci. Tech."},{"key":"10.1016\/j.peptides.2021.170570_bib0010","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2021.170570_bib0015","article-title":"Public health action in emergencies caused by epidemics","volume":"30","author":"Bres","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.peptides.2021.170570_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198175","article-title":"Zoonotic evolution and implications of microbiome in viral transmission and infection","volume":"290","author":"Rajeev","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.552925","article-title":"Strategies for targeting SARS CoV-2: small molecule inhibitors\u2014the current status","volume":"11","author":"Beeraka","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.peptides.2021.170570_bib0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14787210.2019.1635009","article-title":"Broad-spectrum antiviral agents: a crucial pandemic tool","volume":"17","author":"Adalja","year":"2019","journal-title":"Expert Rev. Anti. Ther."},{"key":"10.1016\/j.peptides.2021.170570_bib0035","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current progress in antiviral strategies","volume":"35","author":"Lou","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.peptides.2021.170570_bib0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrmicro1389","article-title":"Parallels among positive-strand RNA viruses, reverse-transcribing viruses and double-stranded RNA viruses","volume":"4","author":"Ahlquist","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.peptides.2021.170570_bib0045","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.peptides.2021.170570_bib0050","doi-asserted-by":"crossref","first-page":"9223","DOI":"10.1128\/JVI.01153-13","article-title":"A cholesterol tag at the N terminus of the relatively broad-spectrum fusion inhibitory peptide targets an earlier stage of fusion glycoprotein activation and increases the peptide\u2019s antiviral potency in vivo","volume":"87","author":"Li","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2021.170570_bib0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.peptides.2021.170570_bib0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4236\/cellbio.2013.24023","article-title":"Natural antimicrobial peptides: pleiotropic molecules in host defense","volume":"02","author":"S\u00e1nchez","year":"2013","journal-title":"CellBio"},{"key":"10.1016\/j.peptides.2021.170570_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines6030063","article-title":"Cathelicidins: immunomodulatory antimicrobials","volume":"6","author":"van Harten","year":"2018","journal-title":"Vaccines"},{"key":"10.1016\/j.peptides.2021.170570_bib0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.semcdb.2018.03.001","article-title":"Mining the tree of life: host defense peptides as antiviral therapeutics","volume":"88","author":"Shartouny","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.peptides.2021.170570_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.it.2008.12.003","article-title":"AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense","volume":"30","author":"Lai","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.peptides.2021.170570_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103886","article-title":"Antibacterial, anti-biofilm and in vivo activities of the antimicrobial peptides P5 and P6.2","volume":"139","author":"Mart\u00ednez","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.peptides.2021.170570_bib0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/ph7050545","article-title":"Human antimicrobial peptides and proteins","volume":"7","author":"Wang","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.peptides.2021.170570_bib0090","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00204","article-title":"Antimicrobial peptides: interaction with model and biological membranes and synergism with chemical antibiotics","volume":"6","author":"Hollmann","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.peptides.2021.170570_bib0095","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: The antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0100","article-title":"LAMP: a database linking antimicrobial peptides","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170570_bib0105","doi-asserted-by":"crossref","DOI":"10.3390\/v11080704","article-title":"Human antimicrobial peptides as therapeutics for viral infections","volume":"11","author":"Ahmed","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.peptides.2021.170570_bib0110","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00018-019-03138-w","article-title":"Antiviral peptides as promising therapeutic drugs","volume":"76","author":"Vilas Boas","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.peptides.2021.170570_bib0115","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2017.00122","article-title":"Cationic antimicrobial peptides inactivate shiga toxin-encoding bacteriophages","volume":"5","author":"Del Cogliano","year":"2017","journal-title":"Front. Chem."},{"key":"10.1016\/j.peptides.2021.170570_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045012","article-title":"Towards the improved discovery and design of functional peptides: common features of diverse classes permit generalized prediction of Bioactivity","volume":"7","author":"Mooney","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170570_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076876","article-title":"Inhibition of influenza a virus infection in vitro by peptides designed in Silico","volume":"8","author":"L\u00f3pez-Mart\u00ednez","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170570_bib0130","article-title":"Analysis and prediction of highly effective antiviral peptides based on random forests","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170570_bib0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/nar\/gks450","article-title":"AVPpred: Collection and prediction of highly effective antiviral peptides","volume":"40","author":"Thakur","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.2000.0757","article-title":"Coronavirus spike proteins in viral entry and pathogenesis","volume":"279","author":"Gallagher","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2021.170570_bib0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virusres.2006.03.001","article-title":"Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein","volume":"120","author":"Sainz","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0150","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1099\/0022-1317-81-12-2867","article-title":"Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity","volume":"81","author":"Taguchi","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.peptides.2021.170570_bib0155","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1074\/jbc.M508381200","article-title":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2021.170570_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170328","article-title":"In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2","volume":"130","author":"Ling","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170570_bib0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0175","first-page":"1","article-title":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor","volume":"5","author":"Lu","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.peptides.2021.170570_bib0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jiph.2017.08.009","article-title":"Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review","volume":"11","author":"Mustafa","year":"2018","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.peptides.2021.170570_bib0185","first-page":"1","article-title":"A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2021.170570_bib0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.peptides.2021.170570_bib0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.peptides.2021.170570_bib0200","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.peptides.2021.170570_bib0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV - A target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.peptides.2021.170570_bib0210","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.aax0902","article-title":"Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling","volume":"367","author":"Loganathan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.peptides.2021.170570_bib0215","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.antiviral.2011.12.012","article-title":"A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2","volume":"94","author":"Struck","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0220","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.peptides.2021.170570_bib0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijid.2009.03.029","article-title":"Manifestations of severe Rift Valley fever in Sudan","volume":"14","author":"Adam","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.peptides.2021.170570_bib0230","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1128\/JVI.01973-12","article-title":"Acid-activated structural reorganization of the rift valley fever virus gc fusion protein","volume":"86","author":"de Boer","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2021.170570_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002430","article-title":"A fusion-inhibiting peptide against rift valley fever virus inhibits multiple, diverse viruses","volume":"7","author":"Koehler","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.peptides.2021.170570_bib0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.ento.49.061802.123422","article-title":"Venezuelan equine encephalitis","volume":"49","author":"Weaver","year":"2004","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.peptides.2021.170570_bib0245","series-title":"Handb. Zoonoses","first-page":"409","article-title":"Parainfluenza viral infection","author":"Hsiung","year":"2017"},{"key":"10.1016\/j.peptides.2021.170570_bib0250","series-title":"OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2017","author":"Eloit","year":"2017"},{"key":"10.1016\/j.peptides.2021.170570_bib0255","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4269\/ajtmh.2011.11-0006","article-title":"Competency of reptiles and amphibians for eastern equine encephalitis virus","volume":"85","author":"White","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.peptides.2021.170570_bib0260","doi-asserted-by":"crossref","DOI":"10.7774\/cevr.2014.3.1.58","article-title":"Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses","volume":"3","author":"Go","year":"2014","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","article-title":"Encephalitic alphaviruses","volume":"140","author":"Zacks","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.peptides.2021.170570_bib0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2019.02.002","article-title":"Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections","volume":"164","author":"Ahmed","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2018.07.025","article-title":"LL-37 disrupts the Kaposi\u2019s sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells","volume":"158","author":"Brice","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0280","series-title":"Emerg. Infect. Dis. Clin. Case Stud","first-page":"95","article-title":"Lujo virus hemorrhagic fever","author":"Paweska","year":"2014"},{"key":"10.1016\/j.peptides.2021.170570_bib0285","first-page":"1","volume":"Vol. 9","author":"King","year":"2011"},{"key":"10.1016\/j.peptides.2021.170570_bib0290","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijantimicag.2003.07.022","article-title":"Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus","volume":"23","author":"Albiol Matanic","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.peptides.2021.170570_bib0295","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/v4102317","article-title":"Jun\u00edn virus pathogenesis and virus replication","volume":"4","author":"Grant","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.peptides.2021.170570_bib0300","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1128\/JVI.01133-14","article-title":"Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism","volume":"88","author":"Spence","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2021.170570_bib0305","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biotechadv.2010.11.008","article-title":"Review of dengue virus and the development of a vaccine","volume":"29","author":"Murrell","year":"2011","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.peptides.2021.170570_bib0310","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.7150\/ijms.21875","article-title":"Peptides as therapeutic agents for dengue virus","volume":"14","author":"Chew","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.peptides.2021.170570_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide inhibitors of dengue virus and West Nile virus infectivity","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.peptides.2021.170570_bib0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050995","article-title":"Release of Dengue Virus Genome Induced by a Peptide Inhibitor","volume":"7","author":"Lok","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170570_bib0325","series-title":"Diseases of Poultry","first-page":"109","article-title":"Newcastle disease, other avian paramyxoviruses, and avian metapneumovirus infections","author":"Suarez","year":"2020"},{"key":"10.1016\/j.peptides.2021.170570_bib0330","article-title":"A review of virulent Newcastle disease viruses in the United States and the role of wild birds in viral persistence and spread","volume":"48","author":"Brown","year":"2017","journal-title":"Vet. Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0335","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00705-001-0778-y","article-title":"Novel peptides that inhibit the propagation of Newcastle disease virus","volume":"147","author":"Ramanujam","year":"2002","journal-title":"Arch. Virol."},{"key":"10.1016\/j.peptides.2021.170570_bib0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/01652176.2015.1126869","article-title":"Avian infectious bronchitis virus in Africa: a review","volume":"36","author":"Khataby","year":"2016","journal-title":"Vet. Q."},{"key":"10.1016\/j.peptides.2021.170570_bib0345","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virol.2011.05.001","article-title":"Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins","volume":"416","author":"Wang","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.peptides.2021.170570_bib0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060302","article-title":"Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action","volume":"8","author":"Hollmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170570_bib0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036833","article-title":"A general strategy to endow natural fusion-protein-derived peptides with potent antiviral activity","volume":"7","author":"Pessi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2021.170570_bib0360","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.peptides.2005.11.018","article-title":"Structural analysis of peptides that interact with Newcastle disease virus","volume":"27","author":"Chia","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2021.170570_bib0365","doi-asserted-by":"crossref","DOI":"10.3390\/ph9030053","article-title":"The role of antimicrobial peptides in influenza virus infection and their potential as antiviral and immunomodulatory therapy","volume":"9","author":"Hsieh","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.peptides.2021.170570_bib0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.biotechadv.2018.01.004","article-title":"Designing improved active peptides for therapeutic approaches against infectious diseases","volume":"36","author":"Gomes","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.peptides.2021.170570_bib0375","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10989-006-9041-4","article-title":"Antiviral activity of antimicrobial lipopeptide from Bacillus subtilis fmbj against pseudorabies virus, porcine parvovirus, Newcastle Disease Virus and infectious bursal disease virus in vitro","volume":"12","author":"Huang","year":"2006","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.peptides.2021.170570_bib0380","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1007\/s00253-017-8396-0","article-title":"Biological activity of lipopeptides from Bacillus","volume":"101","author":"Zhao","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.peptides.2021.170570_bib0385","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3382\/ps.2009-00461","article-title":"Swine intestine antimicrobial peptides inhibit infectious bronchitis virus infectivity in chick embryos","volume":"89","author":"Sun","year":"2010","journal-title":"Poult. Sci."},{"key":"10.1016\/j.peptides.2021.170570_bib0390","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1073\/pnas.86.23.9159","article-title":"Antibacterial peptides from pig intestine: isolation of a mammalian cecropin","volume":"86","author":"Lee","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2021.170570_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-014-0273-8","article-title":"Cecropin P1 inhibits porcine reproductive and respiratory syndrome virus by blocking attachment","volume":"14","author":"Guo","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.peptides.2021.170570_bib0400","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/03079457.2011.646237","article-title":"The long view: 40 years of avian leukosis research","volume":"41","author":"Payne","year":"2012","journal-title":"Avian Pathol."},{"key":"10.1016\/j.peptides.2021.170570_bib0405","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-019-2192-2","article-title":"A novel Bursin-like peptide as a potential virus inhibitor and immunity regulator in SPF chickens infected with recombinant ALV","volume":"15","author":"Zeng","year":"2019","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0410","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.meegid.2015.07.024","article-title":"Evolutionary characterization of Tembusu virus infection through identification of codon usage patterns","volume":"35","author":"Zhou","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.peptides.2021.170570_bib0415","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00018-010-0357-z","article-title":"Dengue virus life cycle: viral and host factors modulating infectivity","volume":"67","author":"Rodenhuis-Zybert","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.peptides.2021.170570_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms15672","article-title":"A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses","volume":"8","author":"Yu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.peptides.2021.170570_bib0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2020.108708","article-title":"Peptide inhibitors of tembusu virus infection derived from the envelope protein","volume":"245","author":"Zhao","year":"2020","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.peptides.2021.170570_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-6-74","article-title":"Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2","volume":"6","author":"Rajik","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.peptides.2021.170570_bib0435","doi-asserted-by":"crossref","first-page":"543","DOI":"10.7150\/ijbs.5.543","article-title":"A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells","volume":"5","author":"Rajik","year":"2009","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.peptides.2021.170570_bib0440","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/vr.117.10.240","article-title":"Bovine virus diarrhoea-mucosal disease infection in cattle","volume":"117","author":"Duffell","year":"1985","journal-title":"Vet. Rec."},{"key":"10.1016\/j.peptides.2021.170570_bib0445","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1099\/0022-1317-78-6-1357","article-title":"Phylogenetic analysis of pestiviruses from domestic and wild ruminants","volume":"78","author":"Becher","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.peptides.2021.170570_bib0450","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1099\/0022-1317-78-4-725","article-title":"Molecular characterization of ovine pestiviruses","volume":"78","author":"Vil\u010dek","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.peptides.2021.170570_bib0455","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2460\/javma.1978.172.04.449","article-title":"Specific immune tolerance in an apparently healthy bull persistently infected with bovine viral diarrhea virus","volume":"172","author":"Coria","year":"1978","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.peptides.2021.170570_bib0460","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1292\/jvms.10-0254","article-title":"Bovine viral diarrhea virus (BVDV) infection in relation to fertility in heifers","volume":"73","author":"Kale","year":"2011","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.peptides.2021.170570_bib0465","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.theriogenology.2003.06.003","article-title":"Effect of bovine viral diarrhea virus infection on fertility of dairy heifers","volume":"61","author":"Mu\u00f1oz-Zanzi","year":"2004","journal-title":"Theriogenology"},{"key":"10.1016\/j.peptides.2021.170570_bib0470","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2460\/ajvr.1990.51.11.1847","article-title":"Frequency of association of noncytopathic bovine viral diarrhea virus with bovine neutrophils and mononuclear leukocytes before and after treatment with trypsin","volume":"51","author":"Bolin","year":"1990","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0475","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2460\/javma.1990.196.04.590","article-title":"Thrombocytopenia and hemorrhages in veal calves infected with bovine viral diarrhea virus","volume":"196","author":"Corapi","year":"1990","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.peptides.2021.170570_bib0480","doi-asserted-by":"crossref","DOI":"10.1186\/s12917-019-2067-6","article-title":"Antiviral effects of nisin, lysozyme, lactoferrin and their mixtures against bovine viral diarrhoea virus","volume":"15","author":"Ma\u0142aczewska","year":"2019","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0485","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2016.09.029","article-title":"Antivirals against animal viruses","volume":"133","author":"Villa","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170570_bib0490","article-title":"Lactoferrin: a powerful antimicrobial protein present in milk","volume":"05","author":"Luna-Castro","year":"2017","journal-title":"Adv. Dairy Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104792","article-title":"Coronavirus membrane fusion mechanism offers a potential target for antiviral development","volume":"178","author":"Tang","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.peptides.2021.170570_bib0500","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/tra.12389","article-title":"Fusion of enveloped viruses in endosomes","volume":"17","author":"White","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.peptides.2021.170570_bib0505","doi-asserted-by":"crossref","first-page":"13134","DOI":"10.1128\/JVI.02433-13","article-title":"Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of middle east respiratory syndrome coronavirus","volume":"87","author":"Gao","year":"2013","journal-title":"J. Virol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:32:53Z","timestamp":1759311173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978121000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":101,"alternative-id":["S0196978121000784"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170570","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170570"}}